Frauenheilkunde up2date

LinksSchließen

Referenz

Möbus V, Wandt H, Frickhofen N. et al.
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.

J Clin Oncol 2007;
25: 4187-4193

Bibliographische Angaben herunterladen

Aufrufen in: